
The availability of zzso vaccine technology for delivery of zzso protective zzso at the time West Nile zzso virus was first detected in North America in 1999 contributed to the rapid development of the vaccine candidate against zzso virus described zzso zzso encephalitis zzso the first zzso attenuated vaccine developed with this technology has successfully undergone phase I and II clinical zzso The zzso technology zzso yellow fever virus zzso zzso vaccine strain zzso and zzso genes to deliver the envelope gene of other zzso as zzso zzso zzso zzso acid sequence zzso between the envelope protein zzso of zzso and zzso viruses facilitated targeting attenuating zzso sites to develop the zzso zzso Here we discuss zzso studies with the zzso virus in mice and zzso zzso virus vaccine is less zzso than the commercial zzso zzso vaccine in mice and nonhuman zzso zzso of the virus is determined by the zzso nature of the construct containing attenuating zzso in the zzso zzso virus backbone and three point zzso introduced to alter zzso zzso zzso and 440 in the zzso virus E protein zzso The safety, zzso and efficacy of the zzso vaccine in the zzso model indicate the vaccine candidate is expected to be safe and zzso for zzso 

